CXCL12 and lung cancer: Furthermore, the results of sub-group analyses after stratification based on cancer type indicated that the SDF-1 rs1801157 polymorphism increased the risk of breast cancer, urologic cancer, lung cancer, head and neck cancer, and haematological malignancies.